Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States.
Ma RC, Chan JC. · 2013
Read Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. by Ma RC, Chan JC. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3708105.txt.
Introduction
Ma and Chan review type 2 diabetes in East Asian populations, where the disease is epidemic yet looks different from its European and American forms. East Asian patients typically develop diabetes at a lower body weight and younger age. They carry more fat around the organs at any given weight. They also show early failure of insulin-producing beta cells, on top of insulin resistance.
These patients face higher risks of kidney complications and a tilt toward stroke among cardiovascular outcomes, while cancer is emerging as a leading cause of death. Rising childhood and young-onset diabetes worries the authors most. They call for urgent awareness, earlier diagnosis, and prevention fitted to Asian populations.
Catalog record
| CREATOR | Ma RC, Chan JC. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 111 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States By Ronald CW Ma, Juliana CN Chan Published in: Annals of the New York Academy of Sciences DOI: 10.1111/nyas.12098 ABSTRACT Abstract There is an epidemic of diabetes in Asia. Type 2 diabetes develops in East Asian patients at a lower mean body mass index (BMI) compared with those of European descent. At any given BMI, East Asians have a greater amount of body fat and a tendency to visceral adiposity. In Asian patients, diabetes develops at a younger age and is characterized by early β cell dysfunction in the setting of insulin resistance, with many requiring early insulin treatment. The increasing proportion of young-onset and childhood type 2 diabetes is posing a particular threat, with these patients being at increased risk of developing diabetic complications. East Asian patients with type 2 diabetes have a higher risk of developing renal complications than Europeans and, with regard to cardiovascular complications, a predisposition for developing strokes. In addition to cardiovascular–renal disease, cancer is emerging as the other main cause of mortality. While more research is needed to explain these interethnic differences, urgent and concerted actions are needed to raise awareness, facilitate early diagnosis, and encourage preventive strategies to combat these growing disease burdens. Keywords: type 2 diabetes, East Asians, Chinese, Japanese, Koreans, diabetic complications, pathophysiology, genetics, β cell function, visceral adiposity, gestational diabetes INTRODUCTION The prevalence of diabetes is increasing globally, but the situation is particularly alarming in Asia. In the latest edition of Diabetes Atlas, an estimated 366 million individuals are affected globally, of whom 36% live in the Western Pacific region, with a significant proportion from East Asia.1 While it is evident that, for the same BMI, Asian populations have a higher prevalence of diabetes than their European counterparts,2 there is a need to better understand the factors underlying these interethnic differences. This review summarizes and discusses the epidemiology, pathophysiology, genetics, and socioeconomic factors that may contribute to these interethnic differences. In addition to drawing on epidemiological and clinical studies performed in Asian populations, we also made reference to lessons learned from Asian subjects living in the United States, Europe, or Australia, notably the Japanese Americans in Seattle who have provided invaluable insight into the pathogenesis of type 2 diabetes (T2D) in people of East Asian origin. EPIDEMIOLOGY OF DIABETES IN EAST ASIA Epidemiological studies have documented consistent increases in the prevalence of diabetes across different countries or areas in Asia.2–5 For example, the prevalence of diabetes in China has increased dramatically from around 1% in 1980 to the most recent estimate of 9.7% from a nationwide survey,6 with the disease trends strongly associated with urbanization.7 In a systematic review of 22 studies on diabetes prevalence and associated factors in China from 2000 to 2010, diabetes prevalence increased from 2.6% to 9.7% during this decade, with increasing age, urban residence, positive family history, obesity, and hypertension being common associated risk factors.7 This pattern of increasing prevalence over the last 20 years is mirrored in many Asian countries, as shown by data on the prevalence of known and undiagnosed diabetes, as well as impaired glucose tolerance (IGT) in East Asia (Table 1).1 In addition to ethnic differences within Asian populations, urbanization provides another source of variation in prevalence of diabetes in different areas. A comparison of 35 epidemiological studies from Mainland China, Hong Kong, and Taiwan, noted that Chinese patients living in Hong Kong and Taiwan have a higher prevalence of diabetes than Mainland Chinese.8 The proportion of undiagnosed diabetes was lower in studies from Hong Kong and Taiwan (52.6%, CI: 49.8%, 55.5%) compared to Mainland China (68.6%, CI: 67.4%, 69.7%). This proportion of undiagnosed diabetes was found to be decreased to around 60% in a recent nationwide study in China.6 By comparison, in the United States, only 7 million of the 25.8 million people (27%) with diabetes were undiagnosed.9 [Table: Comparison of prevalence of diabetes, age distribution, and proportion undiagnosed in East Asian countries compared to the United States and Europe] In addition to the large number of individuals with diagnosed and undiagnosed diabetes, there are many at-risk subjects with IGT in East Asian countries (Table 1). The contribution of IGT to the number of subjects with abnormal glucose regulation (IGT+DM) in Asian countries is high (Table 1). This ratio of IGT to total glucose intolerance, termed the epidemicity index, points to an even further increase in the future burden of diabetes in Asia.10 Globally, there is a general decrease in the age of diagnosis for diabetes,11 although the proportion of young- to middle-aged individuals with T2D remains higher in developing countries and Asia.1 In the Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia (DECODA) study, which evaluated 19,845 subjects from Asia, it was noted that the age-specific prevalence of diabetes in urban Chinese and Japanese patients was higher than that in Europeans at 30–69 years of age from the Diabetes Epidemiology: Collaborative Analysis of Diagnostic criteria in Europe (DECODE) study.12,13 The prevalence and proportion of diabetes in patients aged 20–39 in different countries is compared in Table 1. In Taiwan, the prevalence of diagnosed diabetes increased substantially during 2000–2009, according to the Nationwide Health Insurance database. During this period, there was an 80% increase in the total number of diagnosed diabetic individuals, a 55% increase in the prevalence of diabetes, and a 35% increase in age-standardized prevalence. Overall, diabetes incidence increased by 25% during this period, with the increment in men higher than that in women. Alarmingly, in groups aged 20–39 and 40–59, the incidence and prevalence rates in men were 10% higher than those in women in 2000 and 40% higher in 2008.14 DIAGNOSIS OF TYPE 2 DIABETES IN EAST ASIANS Traditionally, the American Diabetes Association (ADA) does not recommend the primary use of the 75 g oral glucose tolerance test (OGTT) to diagnose diabetes in routine clinical practice, although the OGTT remains the gold standard for diagnosis according to the World Health Organization (WHO).15,16 Compared with Europeans in the DECODE study, a higher proportion of Chinese and Japanese men and women display IGT, relative to isolated impaired fasting glucose, across most age groups.12,13 In several epidemiological surveys it was noted that omitting the OGTT and postprandial plasma glucose criteria for diagnosis of T2D would have led to significant underreporting of the prevalence of diabetes in Asian populations. For example, significant decreases in the prevalence of diabetes have resulted from the application of the 1997 ADA criteria compared with the WHO criteria in Hong Kong Chinese.17 Out of 1,513 individuals in a Hong Kong Chinese working population, 27 had a known history of diabetes. Out of the remaining 1486, 29 (1.95%), with a fasting glucose <7 mmol/L, had a 2-h plasma glucose ≥ 11.1 mmol/L, whereas 8 individuals (0.53%), without a prior diagnosis of diabetes according to the WHO criteria, had a fasting glucose between 7.0 and 7.8 mmol/L and were classified to have diabetes according to the 1997 ADA criteria.17 In the DECODA study, which involved 11 population-based studies from Asia, only 37% of subjects diagnosed with diabetes using either elevated fasting glucose or abnormal OGTT fulfilled both diagnostic criteria.18